Recombinant Human Thrombopoietin Treatment Promotes Hematopoiesis Recovery in Patients with Severe Aplastic Anemia Receiving Immunosuppressive Therapy

Objective. To assess the effectiveness of recombinant human thrombopoietin (rhTPO) in severe aplastic anemia (SAA) patients receiving immunosuppressive therapy (IST). Methods. Eighty-eight SAA patients receiving IST from January 2007 to December 2012 were included in this retrospective analysis. Of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huaquan, Dong, Qi'e, Fu, Rong, Qu, Wen, Ruan, Erbao, Wang, Guojin, Liu, Hong, Wu, Yuhong, Song, Jia, Xing, Limin, Guan, Jing, Li, Lijuan, Shao, Zonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377357/
https://www.ncbi.nlm.nih.gov/pubmed/25861635
http://dx.doi.org/10.1155/2015/597293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377357/
https://www.ncbi.nlm.nih.gov/pubmed/25861635
http://dx.doi.org/10.1155/2015/597293

Ejemplares similares